Mario Delgado Mora

Title: Innovations of Mario Delgado Mora

Introduction

Mario Delgado Mora is a notable inventor based in Granada, Spain. He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, his work focuses on the modulation of the immune system, which is crucial for treating various disorders.

Latest Patents

Delgado Mora's latest patents include "Cell populations having immunoregulatory activity, method for isolation and uses." This invention provides a population of connective tissue-derived cells that respond to interferon-gamma (IFN-γ) by expressing indolamine-2,3-dioxygenase (IDO). These cells are intended for use in preventing, treating, or ameliorating symptoms associated with disorders where immune system modulation is beneficial. This includes autoimmune diseases, inflammatory disorders, and immunologically mediated diseases, such as the rejection of transplanted organs and tissues.

Career Highlights

Throughout his career, Mario Delgado Mora has worked with prominent companies such as Tigenix, S.A.U. and the Consejo Superior de Investigaciones Científicas. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of immunology.

Collaborations

Delgado Mora has collaborated with notable colleagues, including Dirk Büscher and Manuel Angel González De La Peña. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mario Delgado Mora's contributions to immunology through his patents demonstrate his commitment to advancing medical science. His innovative work has the potential to significantly impact the treatment of various immune-related disorders.